Content provided in partnership with

Paradigm Forms $55m Collaboration With Monsanto

BT Catalyst, Jan, 2000

Paradigm Genetics Inc. of Research Triangle Park has signed a broad collaboration agreement with Monsanto Co. (Nyse: MTC) of Madison, N.J., in the field of functional genomics.

Under the terms of the agreement, Paradigm will develop functional genomics data by analyzing the product of Monsanto's gene sequencing, bioinformatics and functional genomics research.

Under terms of the agreement, Paradigm will receive $55 million in committed payments. Additional financial terms were not disclosed.

Paradigm brings to this collaboration its expertise in gene function analysis and bioinformatics. Paradigm's high-throughput analysis methodology is composed of a series of proprietary analytical processes combined with a computerized knowledge base of plant and fungal functional genomics.

Most Popular Articles in Technology: An overview of continuous data protection; Why all those current ratings?; Many countries now have a mobile penetration rate above 100%, report says; The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...; MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...; More »

"We believe this collaboration with Monsanto, a leader in the commercialization of novel agricultural products, validates Paradigm's industrial scale gene function platform," said John Ryals, PhD, chief executive officer and president of Paradigm. "It also allows us the financial resources to Focus our in-house efforts on other applications of the technology, in areas such as human health, nutrition, industrial applications and crop production."

Technology Industry

Paradigm Forms $55m Collaboration With Monsanto

BT Catalyst, Jan, 2000

Find Research Guides for:

Find Featured Titles for: News

Most Popular Articles in Technology

Most Popular Publications in Technology